Open Nav

Heat Biologics

Company updates; target investors and partners

  • Date:Wednesday, October 17
  • Time:3:45 PM - 4:00 PM
  • Room:Elizabethan A
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:Heat Biologics a biopharmaceutical company that develops immunotherapies to activate a patient’s immune system against cancer through T-cell activation.
  • Company Website:www.heatbio.com
  • Company HQ City:Durham
  • Company HQ Country:United States
  • Company HQ State:North Carolina       
  • Ticker:HTBX
  • Exchange:NASDAQ
  • CEO/Top Company Official:Jeff Wolf
  • Year Founded:2008
  • Main Therapeutic Focus:Immunology
  • Lead Product in Development :HS-110
  • Development Phase of Primary Product:Phase II
Back